Scinai Immunotherapeutics Ltd. ADR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCNI and other ETFs, options, and stocks.About SCNI
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.
CEOAmir Reichman
CEOAmir Reichman
Employees45
Employees45
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2003
Founded2003
Employees45
Employees45
SCNI Key Statistics
Market cap398.94K
Market cap398.94K
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume6.81M
Average volume6.81M
High today$0.5938
High today$0.5938
Low today$0.5451
Low today$0.5451
Open price$0.5787
Open price$0.5787
Volume42.64K
Volume42.64K
52 Week high$15.50
52 Week high$15.50
52 Week low$0.5451
52 Week low$0.5451
SCNI News
Investing.com 4d
Scinai secures CDMO deal, raises $5.3M in financing - Investing.com...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.